William Mack & Associates
DXCM icon

William Mack & Associates’s DexCom DXCM Stock Holding History

William Mack & Associates’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.04K Buy
+12
New +$999 ﹤0.01% 728

Other funds holding DXCM

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

William Mack & Associates's DXCM Position: Q3 2026 in Review

William Mack & Associates opened a new position in DexCom (DXCM) in Q3 2026: 12 shares worth $1.04K. The stake represents ﹤0.01% of the portfolio and ranks #728 among its holdings.

863 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

  • William Mack & Associates held 12 shares of DexCom worth $1.04K as of Q3 2026.
  • DexCom was a new William Mack & Associates position in Q3 2026.
  • DexCom made up ﹤0.01% of William Mack & Associates's portfolio in Q3 2026, its #728 holding.
  • 863 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on William Mack & Associates's 13F filing for Q3 2026, filed 27 Oct 2026.